Summary & Overview
CPT 67025: Injection of Vitreous Substitute (Gas or Silicone)
CPT code 67025 covers the intraocular injection of a vitreous substitute (gas, silicone, or spreading agent) used to replace removed vitreous or to maintain/regain intraocular pressure during vitreoretinal surgery. This procedure is clinically significant for management of retinal detachments, complicated vitreous hemorrhage, and other posterior segment conditions where a tamponade or volume replacement is required. Nationally, accurate coding for 67025 affects surgical bundling, facility payment classification, and clinical documentation for ophthalmology practices and surgical centers.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of where 67025 fits in the surgical service line, typical sites of service (hospital operating room and ambulatory surgical center), and the clinical contexts that prompt use of a vitreous substitute. The publication also summarizes common billing considerations, typical modifiers used by payers, and related coding topics relevant to claim adjudication and documentation practices.
This summary is intended for a national audience of coding professionals, surgical administrators, and clinicians seeking a concise reference on the clinical purpose, billing context, and payer landscape for CPT code 67025.
Billing Code Overview
CPT code 67025 describes the injection of a vitreous substitute (such as gas, silicone, or a spreading agent) into the eye to replace vitreous removed during a procedure or to maintain or regain intraocular pressure. This service is typically part of vitreoretinal surgical procedures and is performed by ophthalmology providers.
-
Service type: Intraocular injection of vitreous substitute as part of vitreoretinal surgery
-
Typical site of service: Hospital operating room or ambulatory surgical center
Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient presents with a retinal detachment and undergoes pars plana vitrectomy. During the procedure the surgeon removes vitreous gel and repairs the retina; to tamponade the retina and re-establish or maintain intraocular pressure, the provider injects a vitreous substitute such as perfluoropropane gas or silicone oil into the vitreous cavity. The clinical workflow includes preoperative consent and anesthesia evaluation (local with monitored anesthesia care or general anesthesia for complex cases), sterile operating room setup, vitrectomy and membrane peeling as indicated, fluid–air exchange followed by instillation of the selected gas or silicone oil (CPT 67025), postoperative positioning instructions, short-term intraocular pressure monitoring in the recovery area, and scheduled follow-up visits to assess retinal reattachment and determine timing for gas absorption or silicone oil removal if indicated. Common inpatient/outpatient sites of service include ambulatory surgery centers and hospital operating rooms. Patient factors such as complex retinal pathology, prior vitrectomy, or the need for scleral buckle or tamponade selection influence the choice of substitute and postoperative plan.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
52 | Reduced services | When a portion of the planned vitreous injection procedure was partially performed or curtailed |